New research part-funded by the NIHR Maudsley Biomedical Research Centre has established sex-specific factors that are linked to prognosis and drug resistance in juvenile myoclonic epilepsy (JME).
By
NIHR Maudsley BRC at 23 Feb 2022
Dr Basak Tas, Dr Amir Englund and Dr Stephen Sharman are all researchers in the Centre for Addiction Research, King’s College London. Recently they published an article in the journal Addiction where they discussed the challenges and advantages that the pandemic has brought through the shift to more remote research. In this blog they summarise their conclusions.
By
NIHR Maudsley BRC at 21 Feb 2022
UK drugs regulator, the Medicine and Healthcare products Regulatory Agency (MHRA) has approved Novavax's Nuvaxovid vaccine, which was trialled at the King's CRF, for use in the UK.
By
NIHR Wellcome King's Clinical Research Facility at 16 Feb 2022
Around one in seven young people in the UK present with a diagnosable mental disorder; the majority are untreated, often resulting in poorer mental/physical health, and social/economic outcomes in adulthood. Early identification and treatment are therefore vital. The MyJournE app uses data from schools and mood monitoring surveys to support young people's mental health.
By
NIHR Maudsley BRC at 11 Feb 2022
Every day, clinicians in mental health services make critical decisions about patient care (e.g. which type of medication or psychosocial treatment to offer). However, only a small number of these clinical decisions for children and people with neurodevelopmental disorders are based on high quality evidence because research studies are typically too small. We are addressing this by using the digital revolution to improve our ability to make research more efficient and thus to bring greater benefits.
By
NIHR Maudsley BRC at 8 Feb 2022